Philippe Robert

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 34(Granted Patents)

Company Filing History:

Sun Pharma Advanced Research Company Limited

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134608 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2024-11-05),

2. 11306069 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2022-04-19),

3. 9439853 - Form of administration of enkephalinase inhibitor (2016-09-13),

4. 9266867 - Piperidinyl monocarboxylic acids as S1P1 receptor agonists (2016-02-23),

5. 9255101 - 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands (2016-02-09),

6. 9242959 - (Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications (2016-01-26),

7. 9029357 - Benzazole derivatives as histamine H4 receptor ligands (2015-05-12),

8. 8809539 - Dicarboxylic acid derivatives as S1P1 receptor agonists (2014-08-19),

9. 8802678 - [object Object] (2014-08-12),

10. 8802664 - Benzazole derivatives as histamine H4 receptor ligands (2014-08-12),

11. 8076329 - Histamine H3-receptor ligands and their therapeutic applications (2011-12-13),

12. 8017646 - [object Object] (2011-09-13),

13. 7432269 - Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents (2008-10-07),

Title: Innovator Philippe Robert: Shaping the Future with Benzimidazole Derivatives

Introduction

Philippe Robert, an accomplished inventor based in Pace, France, has significantly contributed to the field of pharmaceuticals with an impressive portfolio of 13 patents. His innovative work focuses primarily on the development of benzimidazole derivatives, which promise to enhance therapeutic applications and address critical medical needs.

Latest Patents

Among his latest patents, Philippe Robert has developed novel benzimidazole enantiomeric derivatives that serve as dual histamine H1 and histamine H4 receptor ligands. These patents emphasize the preparation processes and their potential therapeutic uses, indicating a strong commitment to advancing healthcare solutions through innovative chemical compounds.

Career Highlights

Throughout his career, Philippe Robert has made notable advancements in his field while working with esteemed organizations like Bioprojet and Sun Pharma Advanced Research Company Limited. His contributions have not only solidified his role as a leading inventor but also showcased his dedication to improving pharmaceutical research and development.

Collaborations

Philippe has collaborated with notable professionals during his career, including Jeanne-Marie Lecomte and Jean-Charles Schwartz. These partnerships highlight the importance of teamwork in fostering innovation and enhancing research outcomes in the competitive landscape of pharmaceuticals.

Conclusion

Philippe Robert's relentless pursuit of innovation in the pharmaceutical industry is evident through his extensive patent portfolio and impactful collaborations. As he continues to develop novel solutions for complex medical challenges, his work serves as an inspiration for future inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.